David Roman

Stock Analyst at Goldman Sachs

(1.05)
# 2217
Out of 5,396 analysts
44
Total ratings
Success rate
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
OMDA Omada Health
Initiates Coverage On: Buy
29
18.63 55.66% 1 Jul 1, 2025
HQY HealthEquity
Maintains: Neutral
94 104
102.16 1.8% 3 Jun 4, 2025
BBNX Beta Bionics
Initiates Coverage On: Neutral
16
13.52 18.34% 1 May 30, 2025
PODD Insulet
Initiates Coverage On: Buy
380
301.05 26.22% 1 May 30, 2025
DOCS Doximity
Maintains: Neutral
80 50
61.69 -18.95% 3 May 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
120 104
93.67 11.03% 2 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 10
8.29 20.63% 4 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
94 82
76.07 7.8% 3 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
24 23
15.67 46.78% 2 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
138 154
134.44 14.55% 2 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
42 24
16.78 43.03% 2 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
63 71
78.5 -9.55% 4 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
64 55
46.13 19.23% 2 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
42
31.01 35.44% 3 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
91 124
142.47 -12.96% 2 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
384 427
395.28 8.02% 2 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
81 90
76.79 17.2% 3 Dec 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
90
104.32 -13.73% 1 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
500
544.47 -8.17% 1 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
274
176.16 55.54% 1 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
83
88.39 -6.1% 1 May 30, 2024